Platelet GPIIb/IIIa receptor occupancy studies using a novel fluoresceinated cyclic Arg-Gly-Asp peptide

Thrombosis Research

Volumn 77, Issue 6, 1995, Pages 543-556

  Tsao, Peter W ^a   Bozarth, Jeffrey M ^a   Jackson, Sharon A ^a,b   Forsythe, Mark S ^a   Flint, Sandra K ^a   Mousa, Shaker A ^a  

^a DUPONT COMPANY   (United States)

^b Divisions ^*  (United States)

Author keywords

Arg Gly Asp; bleeding time; BT; DMP728; Flow cytometry; glycoprotein IIb IIIa complex; GPIIb IIIa; Platelet Functions; Platelet GPIIb IIIa; platelet rich plasma; PRP; Receptor Binding; RGD

Indexed keywords

ANTITHROMBOCYTIC AGENT; CYCLO(DEXTRO 2 AMINOBUTYRYL 2 N METHYLARGINYLGLYCYLASPARTYL 3 AMINOMETHYLBENZOIC ACID) METHANESULFONATE; FLUORESCEIN; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; PEPTIDE;

ARTICLE; BLEEDING TIME; CONTROLLED STUDY; DOG; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; THROMBOCYTE AGGREGATION;

AMINO ACID SEQUENCE; ANIMAL; BINDING, COMPETITIVE; CALIBRATION; DOGS; FLUORESCEIN; FLUORESCEINS; HUMAN; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PLATELET MEMBRANE GLYCOPROTEINS; REGRESSION ANALYSIS;

EID: 0028923234     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(95)00029-1     Document Type: Article

References (23)

1. Fibrinogen, fibrinogen receptors, and the peptides that inhibits these interactions
2. Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly- Asp-specific adhesion receptors
3. Adhesive recognition sequences
4. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody
5. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex
6. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets
7. Antiplatelet efficacy and specificity of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist
8. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist
9. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor
10. Pharmacodynamic study of F(ab′)2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable agina pectoris
11. The dynamics of ligand-receptor interactions. Real-time analyses of association, dissociation, and internalization of an N-formyl peptide and its receptors on the human neutrophil
12. Real-time analysis of the assembly of ligand, receptor, and G protein by quantitative fluorescence flow cytometry
13. Model system evaluating fluorescein-labeled microbeads as internal standards to calibrate fluorescence intensity on flow cytometry
14. Calcium regulation of the platelet membrane glycoprotein IIb-IIIa complex
15. Ca2+- dependent binding of a synthetic Arg-Gly-Asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb-IIIa complex
16. 3 (Platelet GPIIb-IIIa)
17. The platelet membrane glycoprotein IIb-IIIa complex
18. Fluorescent analogs of peptides and hormones
19. Neurotransmitter, hormone, or drug receptor binding methods
20. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation
21. Activation affects access to the platelet receptor for adhesive glycoproteins
22. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa
23. Flow cytometric measurements of cytoplasmic calcium changes in human platelets